

The Vox Markets Podcast
Vox Markets Podcast
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
Episodes
Mentioned books

Oct 30, 2025 • 9min
2226: Hemogenyx CEO on positive progress with leukemia drug
Watch on YouTube
Hemogenyx #HEMO has been given clearance to proceed with the next stage of testing in regard to its HG-CT1 therapy, which is designed to treat leukemia. Hemogenyx's chief executive Vladislav Sandler joins us to talk about the implications of continuing the trials, how they will be structured, and widened with the addition of testing for a group of 12-18 year olds.

Oct 30, 2025 • 6min
2225: Gunsynd returns stellar gold and silver grades on Canadian prospects
Watch on YouTube
Gunsynd's Hamish Harris joins Vox for an update, following the release of high grade gold and silver sampling results from the company's Canadian projects. The Barb project showed high gold grades, while Bear Twit showed high silver, lead, and zinc. Harris also updated on a company Gunsynd has a significant stake in,
Richmond Hill. There, the opportunity in copper looks highly significant too.

Oct 30, 2025 • 6min
2224: EGT cuts attractive deal on Swedish copper project
Watch on YouTube
European Green Transition has announced that it has entered into a six-month option agreement for the potential sale of the Pajala copper project in Sweden. With copper prices riding high, it's a good time to be transacting on copper, and it may be that the deal presages a bigger one in relation to EGT's Olserum rare earths project in Sweden. EGT's chief financial officer Jack Kelly joins us to discuss the implications of the deal, how it fits into EGT's wider strategy, and where the company goes from here

Oct 29, 2025 • 1h 11min
2223: Small-cap Investing with Paul Hill and Paul Scott
Join equity analyst Paul Scott, a seasoned commentator on UK small caps, as he dives into 21 promising stock ideas with host Paul Hill. They explore MJ Gleeson's appeal amidst rising mortgage rates, debate Idox's bid strategies, and assess MPac's recent surge. The duo also tackles Alumasc's undervaluation, Bioventix's competition challenges, and the implications of AI on RWS. Additional highlights include insights into Centaur Media's cash returns, Ingenta's growth potential, and the speculative nature of Creo Medical. An insightful listen for small-cap enthusiasts!

Oct 24, 2025 • 12min
2222: The Gluten-Free Revolution: Tooru’s OAF Brand Takes on Tesco — and the £10m Question!
Watch on YouTube
Tooru plc (AIM: TORU) has announced that its gluten-free brand OAF — born out of its Juvela business — has expanded to eight product listings in Tesco, with week-on-week growth and advanced talks underway with other major supermarket chains. Unlike most gluten-free brands that rely on rice flour, OAF and Juvela use a unique gluten-removed wheat starch, delivering authentic taste and texture that could redefine the category.

Oct 22, 2025 • 1h 16min
2221: Small-cap Investing with Paul Hill and Paul Scott
Watch on YouTube
In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 20 stock ideas. Many apologies too about the quality of my video feed (sound was fine), which may have been caused by a connection &/or broadband issue.
00:00 Health of the UK IPO market and upcoming Shawbrook float.
03:55 Celebrus Technologies
07:45 Paypoint
12:00 Treatt
14:05 Macfarlane
16:35 System1
20:15 XP Power
23:00 Gulf Marine Services
26:55 Supreme
28:50 Tristel
31:50 B&M Retail
36:40 Halfords
39:45 ECO Buildings
44:55 ITV
51:00 Playtech
54:15 Chesterfield Special Cylinders
58:30 Hostelworld
61:40 Brickability
65:50 Watkin Jones
69:35 Severfield
71:55 Time Finance

Oct 22, 2025 • 11min
2220: Q&A with MedPal AI CEO Jason Drummond
Watch on YouTube
MedPal AI has unveiled a fully automated, AI-integrated national distribution centre in Swaffham, enabling it to fulfil over 100,000 prescriptions a month. Backed by a rare DSP licence and fresh funding, this move creates a vertically integrated, low-cost prescription fulfilment model aimed at both NHS and private markets. With AI triage, robotic dispensing, and same-day delivery, MedPal is positioning itself at the forefront of digital healthcare

Oct 21, 2025 • 15min
2219: KEFI's gold production one giant step nearer
Watch on YouTube
KEFI Gold and Copper #KEFI has signed a US$240 million dollar debt deal with two lenders for the development of its Tulu Kapi gold mine in Ethiopia. The closing debt finance allows KEFI to move towards the completion of the equity portion of the funding, for which many local and international investors are already lined up. KEFI's executive chairman joins Vox to provide all the latest news, following what he calls the most significant deal the company's ever done.

Oct 20, 2025 • 1h 21min
2218: Exchange with Richard Crow (Cockney Rebel)
In this investing masterclass, expert stock picker Richard Crow (alias Cockney Rebel) takes me through his view of the markets and latest thoughts on 18 stock ideas:
00:00 Equity outlook, YTD’25 portfolio returns and cash position
05:05 Carclo
13:35 B&M European Retail
16:35 Filtronic
18:35 CML Microsystems
24:05 Anglo‑Eastern Plantations
28:05 Funding Circle
35:00 Journeo (& 47:25)
39:20 GB Group
43:05 Creightons
47:40 Shoezone
49:50 When to sell
51:40 TheWorks.co.uk
57:15 ECO Buildings
59:35 AudioBoom
62:30 Dr Martens
64:40 Hargreaves services
67:15 Zotefoams
73:45 Goodwin
75:35 Videndum

Oct 20, 2025 • 12min
2217: Tests prove Blencowe's graphite among the best in the world
Blencowe's chief executive Mike Ralston joins Vox for an update on results from the latest testwork conducted on graphite from the company's Orom-Cross project in Uganda. Thus far, graphite tested has proved to be of exceptional quality, and highly desirable for potential off-takers and other customers. Ralston also updated on progress with the ongoing definitive feasibility study at Orom-Cross, as well as the upcoming newsflow, which will include drill results and an updated resource.


